GPC3 and inflammatory bowel disease: The wealth of data provided so far is largely supportive of a role of glypican-3 as a marker of hepatocellular rather than gastrointestinal malignancy [37,56], further indicating the unlikely possibility of this protein serving as a cryptic intestinal-specific autoantigen in IBD.